Annual report
2689.TEDINET S100Z3WT
Period2025-07-01 → 2026-06-30
Filed2026-09-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥126.6bn | 2025-07-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥118.6bn | 2023-07-01 → 2024-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2025-07-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2025-07-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.2bn | 2023-07-01 → 2024-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.8bn | 2025-07-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-07-01 → 2024-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥46.7bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥43.2bn | at 2024-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.9bn | at 2023-06-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥40.0bn | at 2022-06-30v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.6bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥13.1bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.4bn | at 2024-06-30v | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2023-06-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥9.1bn | at 2022-06-30v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2023-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.1bn | at 2022-06-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥865m | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.4bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥673m | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥212m | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥591m | 2025-07-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2023-07-01 → 2024-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2021-07-01 → 2022-06-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥187.67 | 2025-07-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥251.68 | 2023-07-01 → 2024-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,203.27 | at 2026-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,068.59 | at 2025-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,922.58 | at 2024-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,712.19 | at 2023-06-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,513.91 | at 2022-06-30v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 28.0% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.3% | at 2024-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.8% | 2025-07-01 → 2026-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2024-07-01 → 2025-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2023-07-01 → 2024-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.6% | 2022-07-01 → 2023-06-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2021-07-01 → 2022-06-30v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,405 | at 2026-06-30 | Cons. | Number of employees |
| Employees | 1,393 | at 2025-06-30 | Cons. | Number of employees |
| Employees | 1,354 | at 2024-06-30v | Cons. | Number of employees |
| Employees | 1,317 | at 2023-06-30v | Cons. | Number of employees |
| Employees | 1,289 | at 2022-06-30v | Cons. | Number of employees |
| Revenue | ¥2.7bn | 2025-07-01 → 2026-06-30 | Standalone | Net sales |
| Revenue | ¥2.7bn | 2024-07-01 → 2025-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2023-07-01 → 2024-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2022-07-01 → 2023-06-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2021-07-01 → 2022-06-30v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2025-07-01 → 2026-06-30 | Standalone | Operating income |
| Operating income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2025-07-01 → 2026-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2024-07-01 → 2025-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥672m | 2023-07-01 → 2024-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥631m | 2022-07-01 → 2023-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-07-01 → 2022-06-30v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥995m | 2025-07-01 → 2026-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Income before income taxes |
| Net income | ¥934m | 2025-07-01 → 2026-06-30 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2024-07-01 → 2025-06-30 | Standalone | Profit loss |
| Net income | ¥592m | 2023-07-01 → 2024-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥549m | 2022-07-01 → 2023-06-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥999m | 2021-07-01 → 2022-06-30v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.7bn | at 2026-06-30 | Standalone | Assets |
| Total assets | ¥10.5bn | at 2025-06-30 | Standalone | Assets |
| Total assets | ¥8.5bn | at 2024-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2023-06-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2022-06-30v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2026-06-30 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2025-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.9bn | at 2026-06-30 | Standalone | Net assets |
| Net assets / equity | ¥5.4bn | at 2025-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2024-06-30v | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2023-06-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.7bn | at 2022-06-30v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥681m | at 2026-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥157.57 | 2025-07-01 → 2026-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.4 | 2024-07-01 → 2025-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.31 | 2023-07-01 → 2024-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.25 | 2022-07-01 → 2023-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥164.46 | 2021-07-01 → 2022-06-30v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2025-07-01 → 2026-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2024-07-01 → 2025-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2023-07-01 → 2024-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-07-01 → 2023-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-07-01 → 2022-06-30v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥992.17 | at 2026-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥917.19 | at 2025-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥815.07 | at 2024-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥809.18 | at 2023-06-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥775.62 | at 2022-06-30v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.1% | at 2026-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.7% | at 2025-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2024-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.1% | at 2023-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-06-30v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2025-07-01 → 2026-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.2% | 2024-07-01 → 2025-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2023-07-01 → 2024-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2022-07-01 → 2023-06-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2021-07-01 → 2022-06-30v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,250,000 | at 2026-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2025-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2024-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2023-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2022-06-30v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 45 | at 2026-06-30 | Standalone | Number of employees |
| Employees | 50 | at 2025-06-30 | Standalone | Number of employees |
| Employees | 51 | at 2024-06-30v | Standalone | Number of employees |
| Employees | 47 | at 2023-06-30v | Standalone | Number of employees |
| Employees | 41 | at 2022-06-30v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-07-01 → 2026-06-30 | ¥184m |
| Reconciling Itemsreconciling | depreciation | 2025-07-01 → 2026-06-30 | ¥24m |
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2026-06-30 | −¥1.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2026-06-30 | −¥1.9bn |
| Reconciling Itemsreconciling | segment assets | at 2026-06-30 | −¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2026-06-30 | −¥152m |
| Care Nursing Goodsreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥9m |
| Care Nursing Goodsreportable segment | employees | at 2026-06-30 | 150 pure |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥2.9bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥2.9bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥246,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2026-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥245m |
| Medical Equipmentreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥1.3bn |
| Medical Equipmentreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥684m |
| Medical Equipmentreportable segment | employees | at 2026-06-30 | 1026 pure |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥119.5bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥117.7bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥1.7bn |
| Medical Equipmentreportable segment | segment assets | at 2026-06-30 | ¥42.4bn |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥1.5bn |
| SPDreportable segment | capex | 2025-07-01 → 2026-06-30 | ¥30m |
| SPDreportable segment | depreciation | 2025-07-01 → 2026-06-30 | ¥22m |
| SPDreportable segment | employees | at 2026-06-30 | 184 pure |
| SPDreportable segment | revenue | 2025-07-01 → 2026-06-30 | ¥6.1bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2026-06-30 | ¥6.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥133m |
| SPDreportable segment | segment assets | at 2026-06-30 | ¥7.0bn |
| SPDreportable segment | segment profit | 2025-07-01 → 2026-06-30 | ¥120m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-07-01 → 2026-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-07-01 → 2026-06-30 | ¥715m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2026-06-30 | ¥128.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2026-06-30 | ¥126.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2026-06-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-06-30 | ¥50.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2026-06-30 | ¥1.8bn |
| Reconciling Itemsreconciling | capex | 2024-07-01 → 2025-06-30 | ¥122m |
| Reconciling Itemsreconciling | depreciation | 2024-07-01 → 2025-06-30 | ¥22m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2025-06-30 | −¥1.7bn |
| Reconciling Itemsreconciling | segment assets | at 2025-06-30 | −¥3.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2025-06-30 | −¥113m |
| Care Nursing Goodsreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥19m |
| Care Nursing Goodsreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥8m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥2.8bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥144,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2025-06-30 | ¥1.2bn |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥205m |
| Medical Equipmentreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥1.6bn |
| Medical Equipmentreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥571m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥115.9bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥114.3bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.5bn |
| Medical Equipmentreportable segment | segment assets | at 2025-06-30 | ¥42.7bn |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥1.8bn |
| SPDreportable segment | capex | 2024-07-01 → 2025-06-30 | ¥27m |
| SPDreportable segment | depreciation | 2024-07-01 → 2025-06-30 | ¥24m |
| SPDreportable segment | revenue | 2024-07-01 → 2025-06-30 | ¥5.7bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2025-06-30 | ¥5.6bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥129m |
| SPDreportable segment | segment assets | at 2025-06-30 | ¥6.0bn |
| SPDreportable segment | segment profit | 2024-07-01 → 2025-06-30 | ¥114m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-07-01 → 2025-06-30 | ¥603m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2025-06-30 | ¥124.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2025-06-30 | ¥122.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2025-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-06-30 | ¥49.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2025-06-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,719
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Name of group company holding largest amount of investment shares in group | CurrentYearInstant | Original text (Japanese)（株）カワニシ | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)テルモ株式会社 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Footnotes specified investment shares held for purposes other than pure investment largest holding company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Basic policy on human resources strategy employees etc (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)㈱カワニシ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)サンセイ医機㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | Original text (Japanese)日光医科器械㈱ | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | Original text (Japanese)㈱ホスネット・ ジャパン | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | Original text (Japanese)㈱ライフケア | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)なお、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しています。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes additional information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding total amounts of shares of and or loans to unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |